Table 1.
Clinical characteristics of kidney transplant recipients with/without BKPyVAN.
| Total n = 244 |
BKPyVAN n = 17 |
Non-BKPyVAN n = 227 |
p Value | |
|---|---|---|---|---|
| Gender (male) | 124 (50.8%) | 12 (70.6%) | 112 (49.3%) | 0.13 |
| Age (years old) | 55.2 ± 13.1 | 48.4 ± 13.0 | 55.7 ± 12.9 | 0.038 |
| Diabetes | 65 (26.6%) | 4 (23.5%) | 61 (26.9%) | 1.0 |
| Living related donor | 65 (26.6%) | 3 (17.6%) | 62 (27.3%) | 0.57 |
| Dialysis duration (year) | 4.3 ± 4.3 | 5.8 ± 6.0 | 4.1 ± 4.1 | 0.284 |
| Hepatitis virus B | 21 (8.6%) | 0 (0%) | 21 (9.3%) | 0.38 |
| Hepatitis virus C | 31 (12.7%) | 2 (11.8%) | 29 (12.8%) | 1.0 |
| Creatinine (mg/dL) | 3.3 ± 3.1 | 5.7 ± 3.1 | 3.1 ± 3.0 | 0.002 |
| eGFR (mL/min/1.73 m2) | 40 ± 32 | 16 ± 15 | 41 ± 32 | <0.0001 |
| Acute rejection episode | 67 (27.5%) | 1 (5.9%) | 66 (29.1%) | 0.047 |
| Allograft loss | 55 (22.5%) | 9 (52.9%) | 46 (20.3%) | 0.004 |
| Urinary tract cancers a | 20 (8.2%) | 5 (29.4%) | 15 (6.6%) | 0.007 |
| Cancers other than urinary tract cancers | 11 (4.5%) | 0 (0%) | 11 (4.8%) | 1.0 |
| Any cancer | 31 (12.7%) | 5 (29.4%) | 26 (11.5%) | 0.048 |
| Mortality b | 38 (15.6%) | 3 (17.6%) | 35 (15.4%) | 0.734 |
a: Total: 17 urothelial carcinomas (UC) and 3 renal cell carcinomas (RCC); BKPyVAN group: 4 UC and 1 RCC; non BKPyVAN group: 13 UC and 2 RCC. b: Mortality: all-cause mortality.